Concepedia

Jonathan D. Bloom

JD

Statistics

Publications

40

Citations

2.2K

H-Index

28

Active since

1969

Affiliations

Pearl River Community College(Current)

University of Michigan

Pfizer (United States)

University of Southern California

Sensimetrics Corporation

Jonathan D. Bloom is an author at Pearl River Community College specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1969–2022

40

Publications

40

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent

Jonathan D. Bloom, Minu Dutia, Bernard D. Johnson et al. · Journal of Medicinal Chemistry · 1992 · 297 citations · Full text

, , +8

Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers

Robert G. Frykberg, Ian L. Gordon, Alexander M. Reyzelman et al. · Diabetes Care · 2017 · 156 citations

, , +17

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines

Phaik‐Eng Sum, Ving J. Lee, Raymond T. Testa et al. · Journal of Medicinal Chemistry · 1994 · 118 citations

, , +16

Discovery of Pyrano[3,4-<i>b</i>]indoles as Potent and Selective HCV NS5B Polymerase Inhibitors

Ariamala Gopalsamy, Kitae Lim, Gregory Ciszewski et al. · Journal of Medicinal Chemistry · 2004 · 97 citations · Full text

, , +14

Milbemycin-avermectin studies. 5. Total synthesis of milbemycin .beta.3 and its C(12) epimer

Steven R. Schow, Jonathan D. Bloom, Andrew S. Thompson et al. · Journal of the American Chemical Society · 1986 · 94 citations

, , +9

1–5 of 40